vs

Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $75.1M, roughly 1.1× SAUL CENTERS, INC.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -38.1%, a 46.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 10.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 6.2%).

Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

BFS vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$83.1M
$75.1M
BFS
Growing faster (revenue YoY)
PRCT
PRCT
+9.6% gap
PRCT
20.2%
10.6%
BFS
Higher net margin
BFS
BFS
46.7% more per $
BFS
8.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
6.2%
BFS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BFS
BFS
PRCT
PRCT
Revenue
$75.1M
$83.1M
Net Profit
$6.5M
$-31.6M
Gross Margin
64.9%
Operating Margin
65.4%
-4.1%
Net Margin
8.7%
-38.1%
Revenue YoY
10.6%
20.2%
Net Profit YoY
-19.6%
-27.9%
EPS (diluted)
$0.15
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFS
BFS
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$75.1M
$76.4M
Q3 25
$72.0M
$83.3M
Q2 25
$70.8M
$79.2M
Q1 25
$71.9M
$69.2M
Q4 24
$67.9M
$68.2M
Q3 24
$67.3M
$58.4M
Q2 24
$66.9M
$53.4M
Net Profit
BFS
BFS
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$6.5M
$-29.8M
Q3 25
$10.5M
$-21.4M
Q2 25
$10.7M
$-19.6M
Q1 25
$9.8M
$-24.7M
Q4 24
$8.1M
$-18.9M
Q3 24
$14.5M
$-21.0M
Q2 24
$14.4M
$-25.6M
Gross Margin
BFS
BFS
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
73.6%
63.2%
Q2 24
74.2%
59.0%
Operating Margin
BFS
BFS
PRCT
PRCT
Q1 26
-4.1%
Q4 25
65.4%
-40.6%
Q3 25
69.1%
-27.8%
Q2 25
68.7%
-28.0%
Q1 25
66.5%
-39.7%
Q4 24
82.9%
-28.9%
Q3 24
72.8%
-38.4%
Q2 24
75.0%
-50.3%
Net Margin
BFS
BFS
PRCT
PRCT
Q1 26
-38.1%
Q4 25
8.7%
-39.1%
Q3 25
14.6%
-25.7%
Q2 25
15.1%
-24.7%
Q1 25
13.6%
-35.8%
Q4 24
11.9%
-27.6%
Q3 24
21.5%
-35.9%
Q2 24
21.6%
-48.0%
EPS (diluted)
BFS
BFS
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.15
$-0.54
Q3 25
$0.32
$-0.38
Q2 25
$0.33
$-0.35
Q1 25
$0.29
$-0.45
Q4 24
$0.22
$-0.34
Q3 24
$0.48
$-0.40
Q2 24
$0.48
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFS
BFS
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$8.7M
$245.6M
Total DebtLower is stronger
$468.4M
$51.7M
Stockholders' EquityBook value
$307.8M
$347.7M
Total Assets
$2.2B
$487.1M
Debt / EquityLower = less leverage
1.52×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFS
BFS
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$8.7M
$286.5M
Q3 25
$11.8M
$294.3M
Q2 25
$5.3M
$302.7M
Q1 25
$6.5M
$316.2M
Q4 24
$10.3M
$333.7M
Q3 24
$7.2M
$196.8M
Q2 24
$6.9M
$214.1M
Total Debt
BFS
BFS
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$468.4M
$51.6M
Q3 25
$1.6B
$51.6M
Q2 25
$1.6B
$51.5M
Q1 25
$1.5B
$51.5M
Q4 24
$455.8M
$51.5M
Q3 24
$1.5B
$51.4M
Q2 24
$1.4B
$51.4M
Stockholders' Equity
BFS
BFS
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$307.8M
$365.9M
Q3 25
$316.6M
$380.3M
Q2 25
$322.4M
$385.8M
Q1 25
$328.4M
$389.2M
Q4 24
$335.8M
$402.2M
Q3 24
$341.8M
$241.2M
Q2 24
$345.7M
$251.8M
Total Assets
BFS
BFS
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$2.2B
$508.1M
Q3 25
$2.2B
$511.5M
Q2 25
$2.1B
$513.1M
Q1 25
$2.1B
$519.4M
Q4 24
$2.1B
$534.0M
Q3 24
$2.1B
$374.1M
Q2 24
$2.1B
$374.4M
Debt / Equity
BFS
BFS
PRCT
PRCT
Q1 26
0.15×
Q4 25
1.52×
0.14×
Q3 25
5.02×
0.14×
Q2 25
4.85×
0.13×
Q1 25
4.70×
0.13×
Q4 24
1.36×
0.13×
Q3 24
4.37×
0.21×
Q2 24
4.17×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFS
BFS
PRCT
PRCT
Operating Cash FlowLast quarter
$99.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
15.35×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFS
BFS
PRCT
PRCT
Q1 26
Q4 25
$99.8M
$-10.3M
Q3 25
$20.6M
$-6.6M
Q2 25
$26.6M
$-15.0M
Q1 25
$30.4M
$-17.0M
Q4 24
$121.2M
$-32.4M
Q3 24
$26.5M
$-18.8M
Q2 24
$32.1M
$-15.7M
Free Cash Flow
BFS
BFS
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-28.3M
$-19.0M
Q2 24
$-12.5M
$-16.8M
FCF Margin
BFS
BFS
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-42.1%
-32.6%
Q2 24
-18.7%
-31.4%
Capex Intensity
BFS
BFS
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
81.5%
0.4%
Q2 24
66.7%
2.0%
Cash Conversion
BFS
BFS
PRCT
PRCT
Q1 26
Q4 25
15.35×
Q3 25
1.97×
Q2 25
2.48×
Q1 25
3.10×
Q4 24
14.98×
Q3 24
1.83×
Q2 24
2.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BFS
BFS

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons